ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
83.205
-0.51%
US Dollar vs AUD
1.51278
-0.60%
Bitcoin
61,429.01
3.90%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Bristol Myers Squibb Co (BMY)

  7. Bristol Myers Squibb Co (BMY) News

BMY Bristol Myers Squibb Co

43.815
0.115 (0.26%)
Last Updated: 01:04:48
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Bristol Myers Squibb Co BMY NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.115 0.26% 43.815 01:04:48
Open Price Low Price High Price Close Price Previous Close
43.93 43.685 44.33 43.70
more quote information »

Recent News

Date Time Source Heading
01/5/202422:00GLOBEEditas Medicine and Bristol Myers Squibb Extend Alpha-Beta T..
29/4/202420:00PRNUSRepertoire® Immune Medicines and Bristol Myers Squibb..
26/4/202420:59BWCHMP Adopts Positive Opinion Recommending Approval of..
25/4/202421:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
25/4/202420:59BWBristol Myers Squibb Reports First Quarter Financial Results..
23/4/202421:25IHMARKETNEWSApple Loses Market Share in China, GM Surges in Pre-Market..
22/4/202420:59BWBristol Myers Squibb and Cellares Announce a $380M Worldwide..
09/4/202401:30BWKRAZATI (adagrasib) in Combination with Cetuximab..
07/4/202403:15BWBristol Myers Squibb Presents New Interim Long-Term Efficacy..
06/4/202400:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
03/4/202411:08BWEuropean Commission Expands Approval of Bristol Myers..
02/4/202421:59BWBristol Myers Squibb Releases 2023 Environmental, Social and..
29/3/202407:05BWBristol Myers Squibb Announces Pivotal KRYSTAL-12..
29/3/202407:01BWBristol Myers Squibb Provides Update on the First Phase 3..
28/3/202422:30GLOBEPerspective Therapeutics Provides Recent Business Highlights..
27/3/202405:25BWA Bristol Myers Squibb Expande as Iniciativas de Doações..
26/3/202421:59BWBristol Myers Squibb Expands Health Equity Grant Initiatives..
25/3/202423:00BWBristol Myers Squibb to Present Data at the American College..
21/3/202407:45BWBristol Myers Squibb’s Abecma (idecabtagene vicleucel)..
20/3/202421:59BWBristol Myers Squibb Announces CheckMate -9DW Trial..
19/3/202421:59BWBristol Myers Squibb and Ted Danson Empower Those with..
18/3/202423:44BWBristol Myers Squibb Completes Acquisition of Karuna..
16/3/202409:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
15/3/202412:35BWU.S. FDA Approves Bristol Myers Squibb’s Breyanzi® as the..
12/3/202407:16BWBristol Myers Squibb to Report Results for First Quarter..
08/3/202406:23BWU.S. Food and Drug Administration Approves Opdivo®..
07/3/202408:17BWBristol Myers Squibb to Participate in Upcoming Investor..
05/3/202409:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202409:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/3/202408:16BWBristol Myers Squibb Announces Dividend
29/2/202422:59BWBristol Myers Squibb Announces New Data from the Long-Term..
27/2/202408:16BWBristol Myers Squibb to Participate in the TD Cowen 44th..
27/2/202400:35BWBristol Myers Squibb Completes Acquisition of RayzeBio,..
24/2/202410:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/2/202423:34EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
23/2/202422:59BWBristol Myers Squibb Announces Expiration of RayzeBio Tender..
23/2/202408:15EDGAR2Form 8-K - Current report
20/2/202422:59BWU.S. Food and Drug Administration (FDA) Accepts Supplemental..
15/2/202411:57BWBristol Myers Squibb Prices $13 Billion of Senior Unsecured..
15/2/202408:16BWBristol Myers Squibb Recommends Stockholders Reject..
14/2/202422:59BWU.S. Food and Drug Administration Accepts for Priority..
12/2/202422:59BWBristol Myers Squibb and RayzeBio Announce Expiration of HSR..
07/2/202422:59BWBristol Myers Squibb Announces Acceptance of U.S. and EU..
06/2/202401:00BWBristol Myers Squibb Named One of America’s Most JUST..
05/2/202422:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
02/2/202422:59BWBristol Myers Squibb Reports Fourth Quarter and Full-Year..
30/1/202422:59BWRegulatory Applications Accepted in the U.S. and Japan for..
28/1/202402:00BWSubcutaneous Nivolumab (nivolumab and hyaluronidase) Shows..
26/1/202423:13BWBristol Myers Squibb Receives Positive CHMP Opinion for CAR..
26/1/202400:13EDGAR2Form SC TO-T - Tender offer statement by Third Party

Your Recent History

NYSE
BMY
Bristol Myers Squibb
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved